Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Opioid Manag ; 15(1): 43-49, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30855722

RESUMEN

OBJECTIVES: An adequate perioperative analgesia reduces neuroendocrine stress response and postoperative complica-tions. Opioids are the most effective parenteral drugs to control pain and stress response. DESIGN: This is a prospective randomized double-blinded controlled study. SETTING: Institutional tertiary level. PATIENTS, PARTICIPANTS: Fifty patients underwent general anesthesia with desflurane for laparoscopic cholecystectomy. MAIN OUTCOME MEASURES: To compare two different doses of remifentanil (0.15 mcg/kg/min or 0.3 mcg/kg/min) in reducing markers of stress. Perioperative stress was assessed through the dosage of adrenocorticotropic hormone (ACTH), cortisol, growth hormone (GH), and prolactin (PRL). Three venous blood samples were collected from patients: before transferring the patient to the operating room (Time 0), at the trocar insertion (Time 1), and 1 hour after the end of the surgery (Time 2). RESULTS: Hemodynamic parameters showed no differences between the two groups. The authors observed an increase of GH and PRL in both groups at trocar insertion (Time 1) (p = 0.473 and 0.754, respectively). ACTH and cortisol showed a decrease at Time 1 and an increase after surgery (p = 0.586). The modification of stress parameters levels showed no significant differences between the two groups. CONCLUSIONS: The results of our study showed that a lower dose of remifentanil is equally effective in controlling stress hormones during laparoscopic cholecystectomy.


Asunto(s)
Analgésicos Opioides/uso terapéutico , Colecistectomía Laparoscópica , Remifentanilo/uso terapéutico , Estrés Fisiológico/efectos de los fármacos , Colecistectomía Laparoscópica/efectos adversos , Relación Dosis-Respuesta a Droga , Hormonas/sangre , Humanos , Estudios Prospectivos
4.
J Clin Anesth ; 35: 40-46, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27871564

RESUMEN

PURPOSE: Postoperative cognitive dysfunction is a frequent complication occurring in geriatric patients. Type of anesthesia and the patient's inflammatory response may contribute to postoperative cognitive dysfunction (POCD). In this prospective randomized double-blinded controlled study we hypothesized that intraoperative remifentanil may reduce immediate and early POCD compared to fentanyl and evaluated if there is a correlation between cognitive status and postoperative inflammatory cytokines level. METHODS: Six hundred twenty-two patients older than 60 years undergoing major abdominal surgery were randomly assigned to two groups and treated with different opioids during surgery: continuous infusion of remifentanil or fentanyl boluses. Twenty-five patients per group were randomly selected for the quantitative determination of serum interleukin (IL)-1ß, IL-6, and IL-10 to return to the ward and to the seventh postoperative day. RESULTS: Cognitive status and its correlation with cytokines levels were assessed. The groups were comparable regarding to POCD incidence; however, IL-6 levels were lower the seventh day after surgery for remifentanil group (P= .04). No correlation was found between POCD and cytokine levels. CONCLUSIONS: The use of remifentanil does not reduce POCD.


Asunto(s)
Abdomen/cirugía , Analgesia/efectos adversos , Analgésicos Opioides/efectos adversos , Cognición/efectos de los fármacos , Fentanilo/efectos adversos , Piperidinas/efectos adversos , Complicaciones Posoperatorias/inducido químicamente , Anciano , Analgésicos Opioides/administración & dosificación , Femenino , Fentanilo/administración & dosificación , Humanos , Infusiones Intravenosas/métodos , Interleucina-10/sangre , Interleucina-1beta/sangre , Interleucina-6/sangre , Masculino , Persona de Mediana Edad , Piperidinas/administración & dosificación , Periodo Posoperatorio , Estudios Prospectivos , Remifentanilo
5.
Clin J Pain ; 24(5): 399-405, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18496304

RESUMEN

OBJECTIVES: Postoperative pain is characterized by a wide variability of patients' pain perception and analgesic requirement. The study investigated the extent to which demographic and psychologic variables may influence postoperative pain intensity and tramadol consumption using patient-controlled analgesia (PCA) after cholecystectomy. METHODS: Eighty patients, aged 18 to 70 years, with an American Society of Anesthesiologists physical status I or II and a body mass index between 18.5 and 24.9, undergoing laparoscopic cholecystectomy were enrolled. Self-rating anxiety scale (SAS) and self-rating questionnaire for depression (SRQ-D) were used--1 day before surgery--to assess patients' psychologic status. General anesthesia was standardized. PCA pump with intravenous tramadol was used for a 24-hour postoperative analgesia. Visual analog scale at rest (VASr) and after coughing (VASi) and tramadol consumption were registered. Pearson's and point biserial correlations, analysis of variance, and step-wise regression were used for statistical analysis. RESULTS: Pearson r showed positive correlations between anxiety, depression, and pain indicators (P<0.05). Moreover, female patients had higher pain indicators (P<0.05). Analysis of variance showed that anxious (P<0.05) and depressed (P<0.001) patients had higher pain indicators, which significantly decreased during the postoperative 24 hours (P<0.00001). Regression analysis revealed that tramadol consumption was predicted by preoperative depression (P<0.001). VASr was predicted by sex and SRQ-D (P<0.05). VASi was predicted by sex and SAS (P<0.05). DISCUSSION: Pain perception intensity was primarily predicted by sex with an additional role of depression and anxiety in determining VASr and VASi, respectively. Patients with high depression levels required a larger amount of tramadol.


Asunto(s)
Analgesia Controlada por el Paciente/psicología , Analgesia Controlada por el Paciente/estadística & datos numéricos , Dimensión del Dolor/efectos de los fármacos , Dolor Postoperatorio/prevención & control , Dolor Postoperatorio/psicología , Medición de Riesgo/métodos , Tramadol/administración & dosificación , Adolescente , Adulto , Anciano , Analgésicos Opioides/administración & dosificación , Femenino , Humanos , Italia/epidemiología , Masculino , Persona de Mediana Edad , Evaluación de Resultado en la Atención de Salud/métodos , Dimensión del Dolor/psicología , Dolor Postoperatorio/epidemiología , Cuidados Preoperatorios/psicología , Cuidados Preoperatorios/estadística & datos numéricos , Factores de Riesgo , Resultado del Tratamiento
6.
Neuroreport ; 18(8): 823-6, 2007 May 28.
Artículo en Inglés | MEDLINE | ID: mdl-17471074

RESUMEN

It is unclear whether shorter wave latencies of middle-latency-auditory-evoked-potentials may be associated to cognitive function other than nondeclarative memory. We investigated the presence of declarative, nondeclarative and dreaming memory in propofol-anaesthetized patients and any relationship to intraoperatively registered middle-latency-auditory-evoked-potentials. An audiotape containing one of two stories was presented to patients during anaesthesia. Patients were interviewed on dream recall immediately upon emergence from anaesthesia. Declarative and nondeclarative memories for intraoperative listening were assessed 24 h after awakening without pointing out positive findings. Six patients who reported dream recall showed an intraoperative Pa latency less than that of patients who were unable to remember any dreams (P<0.001). A high responsiveness degree of primary cortex was associated to dream recall formation during anaesthesia.


Asunto(s)
Anestésicos Intravenosos/farmacología , Sueños , Potenciales Evocados Auditivos/efectos de los fármacos , Recuerdo Mental/efectos de los fármacos , Propofol/farmacología , Estimulación Acústica/métodos , Adolescente , Adulto , Anciano , Anestésicos Intravenosos/uso terapéutico , Femenino , Humanos , Masculino , Recuerdo Mental/fisiología , Persona de Mediana Edad , Propofol/uso terapéutico , Tiempo de Reacción/efectos de los fármacos , Estadísticas no Paramétricas
7.
Ann Ital Chir ; 78(5): 359-65, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-18338538

RESUMEN

Myasthenia gravis (MG) is the prototype of antibody mediated autoimmune disease and results from the production of autoantibodies against the acetylcholine receptor (AChR) of the neuromuscular synapse. Adequate preoperative evaluation of the myasthenic patient must be carried out carefully. Age, sex, onset and duration of the disease as well as the presence of thymoma may determine the response to thymectomy. Specific attention should be paid to voluntary and respiratory muscle strength. The preoperative preparation of MG patients is essential for the success of surgery. It depends on the severity of clinical status and changes if myasthenic patients receive anticholinesterase therapy. Myasthenic patients may have little respiratory reserve, and hence depressant drugs for preoperative premedication should be used with caution and avoided in patients with bulbar symptoms. The anaesthetic management of myasthenic patient must be individualized in according to the severity of the disease and the type of surgery required. The use of regional or local anaesthesia seems warranted whenever possible. General anaesthesia can be performed safely when patient is optimally prepared and neuromuscular transmission is adequately monitored during and after surgery. Adequate postoperative pain control, pulmonary toilet, and avoidance of drugs that interfere with neuromuscular transmission will facilitate tracheal extubation. Myasthenia gravis is a disease with many implications for the safe administration of anaesthesia. The potential for respiratory compromise in these patients requires the anaesthesiologist to be familiar with the underlying disease state, as well as the interaction of anaesthetic and non-anaesthetic drugs with MG.


Asunto(s)
Miastenia Gravis/diagnóstico , Miastenia Gravis/cirugía , Humanos , Cuidados Intraoperatorios , Cuidados Posoperatorios , Cuidados Preoperatorios
8.
Ann Ital Chir ; 78(5): 367-70, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-18338539

RESUMEN

Thymoma is the most frequent type of tumor in the anterior-superior mediastinum. The presentation of thymomas is variable; most are asymptomatic and others present themselves with local compression syndrome or parathymic syndrome; rarely thymomas appear as an acute emergency. Surgery is the treatment of choice for thymic tumors and complete resection is the most important prognostic factor. Surgery with adjuvant radiation is recommended for invasive thymoma. The anaesthetic management of patients with mediastinal thymoma undergoing thymectomy is associated with several risks related to potential airway obstruction, hypoxia and cardiovascular collapse. Patients at high risk of perioperative complications can be identified by the presence of cardiopulmonary signs and symptoms. However, asymptomatic thymomas have been occurred with acute cardiorespiratory complications under general anaesthesia. A careful preoperative evaluation of signs, symptoms, chest X-ray, CT scan, MRI, cardiac echogram and venous angiogram should be helpful to investigate neoplasm presence and the area of invasion; moreover, an adequate airway and cardiovascular management, such as performing an awake intubation in the sitting position, allowing spontaneous and non-controlled ventilation, a rigid bronchoscope available and a standby cardiopulmonary bypass, is suggested to prevent the main life-threatening cardiorespiratory complications.


Asunto(s)
Anestesia , Timectomía , Timoma/cirugía , Neoplasias del Timo/cirugía , Anestesia/efectos adversos , Enfermedades Cardiovasculares/etiología , Enfermedades Cardiovasculares/terapia , Humanos , Trastornos Respiratorios/etiología , Trastornos Respiratorios/terapia , Timectomía/efectos adversos , Timoma/complicaciones , Neoplasias del Timo/complicaciones
9.
Curr Drug Targets ; 6(7): 741-4, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16305451

RESUMEN

In critically ill patients, adequate sedation increases comfort, minimizes stress response and facilitates diagnostic and therapeutic procedures. Propofol (2-, 6-diisopropylphenol) is an intravenous sedative-hypnotic agent popular for sedation in the Intensive Care Unit. The favorable propofol pharmacokinetic, characterized by a three compartment linear model, allows rapid onset and short duration of action. The emergence time from sedation with propofol varies with the depth and the duration of sedation and the patient's bodyweight. Propofol causes hypotension, particularly in volume depleted patients, decreases cerebral oxygen consumption, reduces intracranial pressure and has potent anti-convulsant properties. It is a potent antioxidant, has anti-inflammatory properties and is a bronchodilator. As a consequence of these properties, propofol is being increasingly used in the management of traumatic head injury, status epilepticus, delirium tremens, status asthmaticus and in septic patients. Prolonged use (>48 h) of high doses of propofol (>66 mcg/Kg/min) has been associated with lactic acidosis, bradycardia, and lipidemia in pediatric patients. A rare complication firstly reported in pediatrics patients and also observed in adults is known as "propofol syndrome" characterized by myocardial failure, metabolic acidosis and rhabdomiolysis. Hyperkalemia and renal failure have also been associated with this syndrome. Hypertriglyceridemia and pancreatitis are uncommon complications. A large number of trials have compared the use of propofol with midazolam. Sedation with propofol is associated with adequate sedation in ICU patients, shorter weaning time and earlier tracheal extubation compared to midazolam, but not before ICU discharge.


Asunto(s)
Sedación Consciente , Hipnóticos y Sedantes , Propofol , Sala de Recuperación , Humanos , Hipnóticos y Sedantes/efectos adversos , Hipnóticos y Sedantes/farmacocinética , Hipnóticos y Sedantes/farmacología , Midazolam , Propofol/efectos adversos , Propofol/farmacocinética , Propofol/farmacología
10.
Rays ; 30(4): 289-94, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16792002

RESUMEN

Postoperative management after elective esophagectomy for cancer has not been standardized. Thoracoabdominal incision with associated pain, extended operative time with consequent extracellular fluid shifts, single lung ventilation, potential for prolonged postoperative mechanical ventilation and comorbidities in patients with esophageal cancer, all contribute to high perioperative risk. Respiratory problems remain the major cause of both mortality and morbidity after esophagectomy for cancer. A specific pulmonary disorder, acute respiratory distress syndrome (ARDS) occurs in 10-20% of patients after esophagectomy. ARDS mortality exceeds 50%. Atrial fibrillation, that complicates recovery in 20 to 25% of patients after esophagectomy, contributes to make outcome worse. Anesthesiologists should adopt strategies known to be able to optimize patient outcome. Decreased postoperative mortality and morbidity have been associated with epidural analgesia, bronchoscopy to clear persistent bronchial secretions, intraoperative fluid restriction and early extubation. It has been shown that setting up early respiratory physiotherapy and mobilitation may improve functional recovery.


Asunto(s)
Neoplasias Esofágicas/cirugía , Esofagectomía , Cuidados Posoperatorios/métodos , Complicaciones Posoperatorias/prevención & control , Analgesia/métodos , Neoplasias Esofágicas/mortalidad , Esofagectomía/mortalidad , Fluidoterapia , Humanos , Intubación Intratraqueal , Apoyo Nutricional , Dolor Postoperatorio/prevención & control
11.
Rays ; 30(4): 341-5, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16792011

RESUMEN

Esophagectomy for carcinoma of the esophagus is associated with significant mortality and morbidity. Patients with esophageal cancer have frequently obstruction with dysphagia and they often develop malnutrition. In addition, patients can suffer from chronic aspiration leading to a poor preoperative respiratory status. Thorough preoperative evaluation is essential for assessing the operative risk in the individual patient. Respiratory and cardiac problems are the most common complications and assessment of surgical risk, preoperative performance status, particularly with regard to pulmonary and cardiac risk, is likely to be the most important factor. Clinical findings are more predictive of pulmonary complications than results of testing. Cardiac risk is evaluated according to the American College of Cardiology (ACC)/American Heart Association guidelines. With the identification of risk factors, patients undergoing esophageal surgery could be stratified. Appropriate preoperative risk-reduction strategies can be used to decrease morbidity and mortality rates associated with esophagectomy for cancer.


Asunto(s)
Anestesia/métodos , Neoplasias Esofágicas/cirugía , Esofagectomía , Cuidados Preoperatorios/métodos , Humanos , Complicaciones Posoperatorias/prevención & control , Medición de Riesgo
12.
Rays ; 29(4): 401-5, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15852726

RESUMEN

Surgical resection remains the mainstay of treatment in lung cancer patients. Stratification of preoperative risk should be based on the functional status of pulmonary and cardiac systems usually damaged by cigarette smoking. Preoperative pulmonary evaluation should be performed taking into consideration the specific characteristics of the single patient and the type of surgery planned. Spirometry only may be required or oxygen consumption determination is necessary. Cardiac assessment should be based on clinical and instrumental examinations while invasive tests should be limited to high-risk patients. The potential difficulties in endotracheal intubation and lung isolation, the risk for desaturation during one-lung ventilation, and postoperative pain control should be analyzed.


Asunto(s)
Neoplasias Pulmonares/fisiopatología , Neoplasias Pulmonares/cirugía , Cuidados Preoperatorios , Humanos , Neumonectomía , Complicaciones Posoperatorias/prevención & control , Valor Predictivo de las Pruebas , Pruebas de Función Respiratoria , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA